China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study to Predict Neurological Outcomes in Adults With Cardiac Arrest Treated With Ext... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of intraoperative infusion of dexmedetomidine on the changes of inflammatory... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Transformative Study of Orelabrutinib Combined with Pola-R-CHP Regimen in the First-Lin... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk factors and predictive model for post-aneurysm subarachnoid hemorrhage shunt depen... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, prospective, observational real-world study of Etrasimod in the treatmen... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Modified double snare assisted EMR (mDS-EMR) VS ESD for rectal neuroendocrine tumors sm... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter,phase Ⅲ,randomized open-label clinical study of BL-B01D1 versus chemother... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Radiomics-based habitat analysis and deep learning prediction of EGFR and KRAS gene mut... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Correlation between Visual Quality after SMILE and LASEK Procedures and ... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and safety of targeted biological agents in the treatment of myasthenia gravis... Read More